Lilly Asia Ventures is a leading biomedical venture capital firm focusing on investments in the life sciences and healthcare sectors in Asia, particularly in China. The firm was founded in 2008 and has since expanded its presence with offices in Shanghai, Hong Kong, and San Diego. LAV leverages its strategic partnership with Eli Lilly and Company to provide portfolio companies with deep industry expertise, global network resources, and strategic advice.

Lilly Asia Ventures

Solbosch provides a variety of medical and paramedical specialties. It is equipped with a viral air purifier.

Solbosch

biosyn Arzneimittel GmbH is involved in the pharmaceutical and biotech sectors, specializing in trace elements, particularly high-dose selenium injections, and operates unique GMP-active ingredient manufacturing plants.

Metric
Company Name	Lilly Asia Ventures	Solbosch	biosyn Arzneimittel GmbH
Symbol
MSH ID	COM:LILLYASIAVENTURES	BE:SOLBOSCH	DE:BIOSYN
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Healthcare	Pharmaceuticals
Country		BE	DE
Stage
Employee Count	37
Website	lillyasiaventures.com	solbosch.be	biosyn.de
LinkedIn	lilly-asia-venture-%E7%A4%BC%E6%9D%A5%E4%BA%9A%E6%B4%B2%E5%9F%BA%E9%87%91	le-solbosch	biosyn-arzneimittel-gmbh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			1.46K
Web Traffic Growth			0.82
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:LILLYASIAVENTURES

Lilly Asia Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue